Pelvic and paraaortal radiotherapy with concurrent cisplatin chemotherapy for high risk cervical cancer

被引:0
|
作者
Siekmeyer, B [1 ]
Weiss, E [1 ]
Pradier, O [1 ]
Hess, CF [1 ]
机构
[1] Univ Gottingen, Klin Strahlentherapie & Radioonkol, D-3400 Gottingen, Germany
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:19 / 19
页数:1
相关论文
共 50 条
  • [31] Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer (vol 340, pg 1144, 1999)
    Rose, PG
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (09): : 708 - 708
  • [32] Effect of docetaxel combined with cisplatin chemotherapy with concurrent radiotherapy on short-term prognosis of patients with advanced cervical cancer
    Zhuang, Jiahua
    Kang, Deyuan
    [J]. INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2018, 11 (05): : 4898 - 4904
  • [33] A phase I study of adjuvant intensity-modulated radiotherapy with concurrent paclitaxel and cisplatin for cervical cancer patients with high risk factors
    Pei Shu
    Yali Shen
    Yaqin Zhao
    Feng Xu
    Meng Qiu
    Qiu Li
    Hongfeng Gou
    Dan Cao
    Yu Yang
    Jiyan Liu
    Cheng Yi
    Zhengyin Liao
    Deyun Luo
    Feng Bi
    Xin Wang
    Zhiping Li
    [J]. Medical Oncology, 2015, 32
  • [34] A phase I study of adjuvant intensity-modulated radiotherapy with concurrent paclitaxel and cisplatin for cervical cancer patients with high risk factors
    Shu, Pei
    Shen, Yali
    Zhao, Yaqin
    Xu, Feng
    Qiu, Meng
    Li, Qiu
    Gou, Hongfeng
    Cao, Dan
    Yang, Yu
    Liu, Jiyan
    Yi, Cheng
    Liao, Zhengyin
    Luo, Deyun
    Bi, Feng
    Wang, Xin
    Li, Zhiping
    [J]. MEDICAL ONCOLOGY, 2015, 32 (11)
  • [35] Dosimetric predictors of acute hematologic toxicity in cervical cancer patients treated with concurrent cisplatin and intensity-modulated pelvic radiotherapy
    Mell, Loren K.
    Kochanski, Joel D.
    Roeske, John C.
    Haslam, Josh J.
    Mehta, Neil
    Yamada, S. Diane
    Hurteau, Jean A.
    Collins, Yvonne C.
    Lengyel, Ernst
    Mundt, Arno J.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 66 (05): : 1356 - 1365
  • [36] WEEKLY VERSUS TRI-WEEKLY CISPLATIN-BASED CHEMOTHERAPY CONCURRENT WITH RADIOTHERAPY IN TREATMENT OF CERVICAL CANCER PATIENTS WITH INTERMEDIATE RISK FACTORS.
    Il, P. Sang
    Lee, E. D.
    Kang, G. M.
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2018, 28 : 321 - 321
  • [37] Influence of Pelvic Intensity-Modulated Radiation Therapy With Concurrent Cisplatin-Based Chemotherapy of Cervical Cancer on the Vaginal Microbiome
    Jiang, Li
    Li, Bo
    Zhang, Yong
    Ma, Shanshan
    Liu, Chang
    Liang, Feifei
    Wei, Zhuxin
    Huang, Tingting
    Wang, Rensheng
    [J]. FRONTIERS IN ONCOLOGY, 2021, 11
  • [38] Adjuvant Pelvic Intensity Modulated Radiation Therapy and Concurrent Docetaxel and Cisplatin Chemotherapy for Postoperative Cervical Cancer With Adverse Risk factors: A Retrospective Report on Toxicity and Outcomes
    Zhang, G.
    Fu, C.
    He, E.
    Zhang, Y.
    Cheng, Y.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (02): : S403 - S404
  • [39] Adjuvant intensity-modulated radiotherapy (IMRT) with concurrent paclitaxel and cisplatin in cervical cancer patients with high risk factors: A phase II trial
    Wang, X.
    Shen, Y.
    Zhao, Y.
    Li, Z.
    Gou, H.
    Cao, D.
    Yang, Y.
    Qiu, M.
    Li, Q.
    Liu, J.
    Yi, C.
    Liao, Z.
    Luo, D.
    Xu, F.
    Bi, F.
    [J]. EJSO, 2015, 41 (08): : 1082 - 1088
  • [40] Cisplatin and paclitaxel concurrent to radiotherapy in locally advanced cervical cancer: A phase II study
    Colombo, A.
    Mauri, L.
    Landoni, F.
    Colombo, N.
    Polo, A.
    Guzzetti, R.
    D'Affronto, C.
    Frigerio, L.
    Meregalli, S.
    Maneo, A.
    Mangioni, C.
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2007, 17 (04) : 937 - 937